Intelligence Platform
Patents
Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6576465
Human bone accessory cells
expired patentUS 6569995
Identification of a G protein-coupled receptor transcriptionally regulated by protein tyro
expired patentUS 6544972
Methods of limiting apoptosis of cells
expired patentUS 6534261
Regulation of endogenous gene expression in cells using zinc finger proteins
expired patentUS 6521615
Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying i
expired patentUS 6491908
Selective elimination of T cells that recognize specific preselected targets
expired patentUS 6489165
Chondrocyte-like cells useful for tissue engineering and methods
expired patentUS 6485722
Method for selective engraftment of drug-resistant hematopoietic stem cells
expired patentUS 6479286
Methods and compositions for making dendritic cells from expanded populations of monocytes
expired patentUS 6468537
Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lup
expired patentUS 6451316
Methods for generating antigen-reactive T cells in vitro
expired patentUS 6448045
Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
expired patentUS 6429009
Composition and method of imparting resistivity to HIV superinfection to cells
expired patentUS 6410029
2-methoxyestradiol-induced apoptosis in cancer cells
expired patentUS 6410320
Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kid
expired patentUS 6399372
Monocyte derived cells with immunostimulating properties, their preparation and uses
expired patentUS 6399362
Electrospraying apparatus and method for introducing material into cells
expired patentUS 6399368
Secretion of T cell receptor fragments from recombinant Escherichia coli cells
expired patentUS 6395712
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
expired patentUS 6375946
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero
expired patentUS 6368596
Compositions and methods for homoconjugates of antibodies which induce growth arrest or ap
expired patentUS 6358736
Method for increasing the antigen presenting ability of leukemia cells
expired patentUS 6352694
Methods for inducing a population of T cells to proliferate using agents which recognize T
expired patentUS 6342216
Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
expired